ÀÓ»óÀÇÇÐºÐ¾ß ÇмúÁ¤º¸
Çà»ç¸í 2019 ´ëÇÑÇ÷¾×ÇÐȸ ±¹Á¦Çмú´ëȸ (2019 KSH International Conference & 60th Annual Meeting, ICKSH 2019)
±â°£ 2019.03.14 - 2019.03.16
±Û¾´ÀÌ °ü¸®ÀÚ
÷ºÎÆÄÀÏ

?€?Œëª… : 2019 ?€?œí˜ˆ?¡í•™??êµ? œ?™ìˆ ?€??(2019 KSH International Conference & 60th Annual Meeting, ICKSH 2019)
????: 2019??3??14??ëª? ~ 16????
????: 그랜???Œì»¤???¸í…”
?ˆíŽ˜?´ì? : www.icksh.org


?„로그램:
 
Time VISTA 1 VISTA 2 VISTA 3 Grand Hall
08:00-09:00 Registration
09:00 Opening Remark  
09:00 - 10:30 [JS01] KAI-KSH Joint Symposium
- Immunotherapeutics in Blood Disease
[SS01] Bone Marrow Failure    
Immune checkpoint inhibitor in cancer
(Seung-Woo Lee, Korea)

CAR-T
(Chan Hyuk Kim, Korea)

Cytotoxic T lymphocyte therapy
(Hyewon Lee, Korea)

Immune checkpoint inhibitor in lymphoma
(Dok Hyun Yoon, Korea)
TBD

?€ Germ line mutations in inherited BM failure
(Jean Soulier, France)

Telomere length and somatic mutations in aplastic anaemia
(Dong Soon Lee, Korea)
10:30 - 10:45 Coffee Break
10:45- 11:45 Plenary Lecture I - Gene Therapy in Hematology  
Application of CRISPR/Cas-9 in blood disease
(Matthew H. Porteus, USA)

Gene therapy for hemophilia
(Katherine High, USA)
11:45- 12:45 Presidential Symposium  
Stem cells in AML
(Ravindra Majeti, USA)

Optimal treatment of adolescents and young adult ALL
(Ching-Hon Pui, USA)
12:45 - 13:40 [LS01] [LS02] [LS03]
TBD TBD TBD
13:40 - 14:40 [AS01] Asian Hematology Symposium: Lymphoid [AS02] Asian Hematology Symposium: Myeloid    
NHL in India
(T. Raja, India)

ALL in Taiwan
(Tran-Der Tan, Taiwan)

ALL in Malaysia
(Sen Mui Tan, Malaysia)
TBD

TBD

Hemoglobinopathy in Thailand
(Suradej Hongeng, Thailand)
14:40 - 14:55 Coffee Break
14:55 - 16:25 [JS02] KOGO-KSH Joint Symposium - Genomics for Precision Hematology [SS02] Multiple Myeloma: How is MM Developed and Progressed? From 3 Different Viewpoint [SS03] Transplantation/Cell Therapy [ES01] Iron Metabolism
Understanding angioimmunoblastic T-cell lymphoma: from genomics to animal pathology
(Jaesang Kim, Korea)

Genomic pathogenesis of epstein–barr virus (EBV)- induced diffuse large B cell lymphoma
(Sung-Yup Cho, Korea)

Current status of precision hematology
(Young-Uk Cho, Korea)

Clinical application of precision hematology
(Joon-Ho Moon, Korea)
High risk MM identifyed by genomic analysis
(Gareth Morgan, UK)

What role does bone marrow microenvironment play on MM cells
(Yusuke Furukawa, Japan)

Antigen-mediated regulation in MM
(Madhav Dhodapkar, USA)
TK cell therapy
(Chiara Bonini, Italy)

Updates on CAR T cell therapy for
relapsed/refracoty MM
(Jesús Berdeja, USA)

New insights into cancer vaccine strategies
(Larry Kwak, USA)
Iron metabolism in hemoglobinopathies
(Vip Viprakasit, Thailand)

Deferasirox for iron overload patients: preserving organ functions
(Norbert Gattermann, Germany)

Managing side effects in iron chelation therapy
(Heather Leitch, Canada)
16:25 - 16:40 Break
16:40 - 18:10 [SS04] Myeloproliferative Neoplasm [SS05] Bleeding Disorder/Thrombosis [SS06] Pediatric Disease: Inherited hematologic malignancies [ES02] Indolent Lymphoma: From Genetics to the Clinic
Clinical significance of genetic stratification of MPN patients
(Robert Kralovics , Austria)

Molecular mechanism of MPN development by mutant calreticulin
(Norio Komatsu, Japan)

Interferon treatment for MPN
(Jean-Jacques Kiladjian, France)
Gene therapy for hemophilia
(Glenn F. Pierce, USA)

Individualized treatment for hemophilia : population pharmacokinetics approach
(Cindy Yeung, Canada)

Mechanisms of cancer-associated thrombosis
(Nigel Mackman, USA)
Inherited hematologic malignancies
(Lucy Godley, USA)

GATA2 leukemogenesis
(Jean Donadieu, France)

Roles of monosomy 7 and SAMD9/SAMD9L mutations in myeloid leukemogenesis
(Hirotaka Matsui, Japan)
Mantle cell lymphoma
(Mats Jerkeman, Sweden)

Follicular lymphoma
(Gilles Salles , France)

Chronic lymphocytic leukemia/ small lymphocytic lymphoma
(Wei Xu, China)
18:10 - 18:30 Break
18:30 - 20:00 Welcome Reception

 

 


2018-12-10 ¿ÀÈÄ 4:15:19, Á¶È¸¼ö : 611